Drew Williamson

Cooley advised the underwriters on fashion brand Lulu’s $92 million initial public offering of 5,750,000 shares of common stock, which now trade on the Nasdaq Global Market under the symbol LVLU. Lawyers David Peinsipp, Kristin VanderPas and Denny Won led the Cooley team advising the underwriters.

Cooley advised BowX Acquisition Corp., a publicly traded special purpose acquisition company or SPAC, on its agreement to merge with WeWork for $9 billion – a combination that will result in WeWork becoming a publicly listed company. Lawyers Dave Peinsipp, Jamie Leigh, Kevin Cooper, Garth Osterman, Eric Blanchard, Richard Segal, Sangitha Palaniappa and Natasha Patel led the team advising BowX on the transaction, which is expected to close in Q3.

Cooley advised Hyliion, provider of electrified powertrain solutions for Class 8 commercial vehicles, on its agreement to combine with Tortoise, a publicly traded special purpose acquisition company or SPAC. The transaction, expected to close in Q3, will drive Hyliion’s corporate expansion and further the development and commercialization of its powertrain solutions, along with the support of the company’s robust network of industry partners. Partners Garth Osterman, David Peinsipp and Kristin VanderPas led the Cooley team advising Hyliion on the agreement.  

Cooley advised the underwriters on Health Catalyst's $209.3 million initial public offering of 8,050,000 shares of common stock, including full exercise of the underwriters' option to purchase additional shares. Health Catalyst, whose securities now trade on The Nasdaq Global Select Market under the symbol "HCAT," is a leading provider of data and analytics technology and services to healthcare organizations. Partners Dave Peinsipp, Kristin VanderPas, Charlie Kim and Drew Williamson led the Cooley team. 

Goldman Sachs, J.P. Morgan, and William Blair acted as joint book-running managers. Piper Jaffray, Evercore, and SVB Leerink acted as passive book-running managers. SunTrust Robinson Humphrey acted as co-manager.

Cooley advised the underwriters on Livongo Health's $408.5 million initial public offering of 14,590,050 shares of common stock, including full exercise of the underwriters' option to purchase additional shares. Livongo Health, whose securities now trade on The Nasdaq Global Select Market under the symbol "LVGO", offers a whole person platform that empowers people with chronic conditions to live better and healthier lives, beginning with diabetes and now including hypertension, weight management, diabetes prevention, and behavioral health.

Morgan Stanley, Goldman Sachs, and J.P. Morgan acted as lead joint book-running managers for the offering. Piper Jaffray and SVB Leerink acted as lead co-managers, and Canaccord Genuity, KeyBanc Capital Markets and Needham & Company acted as co-managers for the offering.